A reduced expression of Tjp1 has been observed in various cancer types, including breast, ovarian, and colorectal cancers, and the loss of Tjp1 may contribute to the disruption of cell–cell adhesion and increase cell migration, invasion, and metastasis, all of which are hallmarks of aggressive cancer behavior [30,31,32]. This evidence concerns the gene TJP1 and cancer.